The start of a new year is the perfect time to check in on your brain health. Alzheimer’s Research UK’s Information Services ...

Complete 28 miles throughout February in whichever way you like. Whether you walk, run, cycle or swim, make every mile count and aim to raise £100 for vital dementia research. Join our Facebook group ...

At Alzheimer’s Research UK, we use door-to-door and private site fundraising (where fundraisers work in locations like shopping centres and train stations). You may speak to our fundraisers at your ...

Dr Susan Kohlhaas, our Executive Director of Research and Partnerships talks to us about the dementia drugs that could follow lecanemab and donanemab. And exciting new work that’s going to boost our ...

A challenge event you can take at your own pace. Walk a distance of 10k or 10 miles and see London at night! A fantastic evening walk through London, taking in famous landmarks along a great route ...

Take part in the Chiltern 50 Challenge and raise vital funds for Alzheimer's Research UK. Choose your distance – 10 km, 25 km, or 50 km – and walk, jog, or run at your own pace, while enjoying the ...

Many of our scientists are focussed on developing treatments that can slow down or stop the diseases that cause dementia. This work is vital, as currently there are no drugs available on the NHS that ...

Join 2000 trekkers as we venture 25km across the Capital taking in unrivalled views of the skyline from its best vantage points. Follow a signed route, with free food and drink at regular rest stops, ...

Take on the Gower Peninsula Challenge at your own pace – walk, jog, or run a distance that suits you along a marked route. Along the way, you'll enjoy regular rest stops offering free food, drink, and ...

Get active & explore some of the Capital’s historic areas with a tour of the ‘gateway to London’ along the Thames’s eastern section. Starting alongside the grandeur of Woolwich Royal Artillery ...

Right now, there isn’t a cure for people with dementia. But hope is on the horizon with lecanemab and donanemab – the first Alzheimer’s treatments licensed in Britain that can slow down the disease, ...